RxDoctor Payments Data

Thomas Olson

Family Medicine · Vermillion, SDNPI 1134127087

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $800 and has fallen 89.0% since, to $88 in 2024. Among family medicine clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,256in general payments, 2019–2025

Across 121 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$354
  • Daiichi Sankyo Inc.$244
  • Pfizer$217
  • Sunovion Pharmaceuticals Inc.$216
  • AstraZeneca$195
  • Sanofi-aventis U.S. LLC$152
  • plus $879 from 16 others

What the payments were for

  • Food & beverage$2,256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,256 in reported general payments places this provider in the 90th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArexvyRsvpref3 Antigen/As01e/Pf72$20,648
XareltoRivaroxaban15$7,549
MyrbetriqMirabegron14$5,816
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,309
Boostrix TdapDiphth,pertuss(Acell),tet Vac22$1,412
Celecoxib11$277
Fluoxetine Hcl23$265
Lovastatin11$189
Amlodipine Besylate11$170
Levothyroxine Sodium12$155
Escitalopram Oxalate14$138
Gabapentin18$129
Omeprazole16$76
Ramipril18$75
Rosuvastatin Calcium13$56

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$75$7,54915 claims
Astellas Pharma US IncMyrbetriq$35$5,81614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Vermillion

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →